Amyloid-beta globulomer antibodies
First Claim
Patent Images
1. A hybridoma having American Type Culture Collection designation number PTA-7407.
4 Assignments
0 Petitions
Accused Products
Abstract
The subject invention relates to monoclonal antibodies (e.g., 8F5 and 8C5) that may be used, for example, in the prevention, treatment and diagnosis of Alzheimer'"'"'s Disease or other neurodegenerative disorders.
-
Citations
18 Claims
- 1. A hybridoma having American Type Culture Collection designation number PTA-7407.
-
3. A monoclonal antibody comprising a variable heavy chain encoded by SEQ ID NO:
- 11, wherein the antibody binds amyloid beta globulomer.
- View Dependent Claims (4)
-
5. A monoclonal antibody comprising a variable light chain encoded by SEQ ID NO:
- 12, wherein the antibody binds amyloid beta globulomer.
- View Dependent Claims (6, 7, 8)
-
9. A monoclonal antibody comprising SEQ ID NO:
- 19, wherein the antibody binds amyloid beta globulomer.
- View Dependent Claims (10)
-
11. A monoclonal antibody comprising SEQ ID NO:
- 20, wherein the antibody binds amyloid beta globulomer.
- View Dependent Claims (12)
-
13. A monoclonal antibody comprising a variable light chain and a variable heavy chain, wherein said variable heavy chain comprises complementarity determining regions (CDRs) of SEQ ID NO:
- 13, SEQ ID NO;
14 and SEQ ID NO;
15, wherein said variable light chain comprises CDRs of SEQ ID NO;
16, SEQ ID NO;
17 and SEQ ID NO;
18, and wherein the antibody binds amyloid beta globulomer. - View Dependent Claims (14, 15, 16, 17, 18)
- 13, SEQ ID NO;
Specification